Steven Lin, MD, PhD

MD Anderson Cancer Center
Houston, Texas, United States

Dr. Steven Lin is an Associate Professor and Physician Scientist at MD Anderson Cancer Center, with joint appointments in the Departments of Radiation Oncology and Experimental Radiation Oncology. Dr. Lin’s practice focuses on thoracic malignancies, and he oversees several clinical trials including the use of proton beam therapy for esophageal cancer and in the combination of immunotherapy with radiotherapy in lung and esophageal cancers. Dr. Lin runs a translational research team that evaluates biomarkers for treatment response and disease outcomes after chemoradiation therapy and immunotherapy. On the basic science side, Dr. Lin’s main interests lie in identifying novel approaches that could enhance radiotherapy and immunotherapy combinations in lung cancer that could be translated to innovative clinical trials for patients.

Disclosures:

• Employment: The University of Texas MD Anderson Cancer Center:Professor:Employee
• Compensation: AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: to present ;Creatv Microtech: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: to present ;XRAD Therapeutics: Consultant, Compensation Payment-End Date: to present ;Beyond Spring Pharmaceuticals: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Nektar Therapeutics: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;STCube Pharmaceuticals: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present
• Ownership: Seek Diagnostics:Ownership Equity
• Leadership: none

Presentation(s):

• Enhancing the Successful Translation of Research into Clinical Practice in Radiation Oncology

  Tuesday, October 1, 2024
  4:17 PM – 4:32 PM ET